This site is intended for healthcare professionals only
LoginRegister

Serum institute CEO expects Omicron-specific vaccine in 6 months: Report

Ruchika SharmaWritten by Ruchika Sharma   |  
Serum institute CEO expects Omicron-specific vaccine in 6 months: Report
  • whatsapp
  • Telegram

New Delhi: Serum Institute of India's (SII) Chief Executive Officer Adar Poonawalla said he expects an Omicron-specific vaccine in the country in six months, NDTV reported on Monday.

Read also: SII conducting research to find vaccine against Monkeypox, says Adar Poonawalla

SII, the world's biggest vaccine maker, produces AstraZeneca's COVID-19 vaccine under the brand name Covishield.

SII did not immediately respond to a Reuters request for comment.

Read also: Centre plans to roll out SII qHPV vaccine for girls aged 9-14 years under National Immunization Programme


Serum Institute of IndiaSerum Institute of India newsSIIAdar PoonawallaOmicron specific vaccine
Ruchika Sharma
Ruchika Sharma

    Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

    Show Full Article
    Next Story
    X
    sidekick